Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal

European Journal of Immunology - Tập 46 Số 1 - Trang 13-21 - 2016
Evanna L. Mills1, Luke O'neill1
1Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland

Tóm tắt

Mitochondria are master regulators of metabolism. Mitochondria generate ATP by oxidative phosphorylation using pyruvate (derived from glucose and glycolysis) and fatty acids (FAs), both of which are oxidized in the Krebs cycle, as fuel sources. Mitochondria are also an important source of reactive oxygen species (ROS), creating oxidative stress in various contexts, including in the response to bacterial infection. Recently, complex changes in mitochondrial metabolism have been characterized in mouse macrophages in response to varying stimuli in vitro. In LPS and IFN‐γ‐activated macrophages (M1 macrophages), there is decreased respiration and a broken Krebs cycle, leading to accumulation of succinate and citrate, which act as signals to alter immune function. In IL‐4‐activated macrophages (M2 macrophages), the Krebs cycle and oxidative phosphorylation are intact and fatty acid oxidation (FAO) is also utilized. These metabolic alterations in response to the nature of the stimulus are proving to be determinants of the effector functions of M1 and M2 macrophages. Furthermore, reprogramming of macrophages from M1 to M2 can be achieved by targeting metabolic events. Here, we describe the role that metabolism plays in macrophage function in infection and immunity, and propose that reprogramming with metabolic inhibitors might be a novel therapeutic approach for the treatment of inflammatory diseases.

Từ khóa


Tài liệu tham khảo

10.1038/nri3073

10.1016/j.immuni.2013.04.005

10.1016/j.immuni.2015.02.005

10.1016/j.smim.2015.09.001

Galvan‐Pena S., 2014, Metabolic reprograming in macrophage polarization, Front. Immunol., 5, 420

Krebs H. A., 1980, The role of citric acid in intermediate metabolism in animal tissues, FEBS. Lett., K1

10.1038/nature11986

10.1016/j.tcb.2013.11.008

10.1016/j.chom.2012.07.012

10.1042/BJ20111386

10.1161/ATVBAHA.110.207449

10.1042/BJ20111275

10.1073/pnas.1218599110

10.1128/JB.131.1.136-144.1977

Hillier S., 1981, Glyoxylate bypass enzymes in Yersinia species and multiple forms of isocitrate lyase in Yersinia pestis, J. Bacteriol., 145, 452, 10.1128/jb.145.1.452-458.1981

10.1016/j.cmet.2013.06.018

10.1038/nature09973

10.1042/BJ20081386

10.1021/bi602508x

10.1073/pnas.0510977103

10.1084/jem.20102049

10.1038/cr.2011.20

10.1038/nature09663

10.1016/j.immuni.2013.08.001

10.1016/j.immuni.2012.01.009

10.1038/ni.1980

10.4049/jimmunol.1100613

10.1074/jbc.M115.662114

10.1016/j.cmet.2014.07.011

10.1038/nri978

10.4049/jimmunol.0901698

10.1016/j.cmet.2012.04.023

10.1016/j.cmet.2006.05.011

10.1016/S0092-8674(00)80611-X

10.4049/jimmunol.181.12.8633

10.1038/nature11862

10.12703/P6-13

10.1016/B978-0-12-394307-1.00003-5

10.1016/j.cmet.2014.12.005

10.1016/j.cmet.2013.06.017